 |
|
A Meta-analysis of Controlled Clinical Studies With Diacerein in the Treatment of Osteoarthritis
Bernhard Rintelen, MD;
Kurt Neumann, MS;
Burkhard F. Leeb, MD
Arch Intern Med. 2006;166:1899-1906.
Background This systematic meta-analysis on randomized controlled trials with diacerein was performed to provide an evidence-based assessment of its symptomatic efficacy in the treatment of osteoarthritis.
Methods Electronic databases were searched for randomized controlled trials with diacerein. A manual review of the literature, abstracts, and posters was also conducted. Unpublished final reports were obtained from the manufacturer. Only studies performed in knee and/or hip osteoarthritis were chosen for review. Study inclusion, quality scoring, and data extraction were performed by 2 reviewers independently. Objectives for analysis comprised pain, function, escape medication use, global efficacy, and safety ratings by patients and investigators. Specific study periods, such as the active treatment period and the treatment-free follow-up period (when present), were analyzed. Statistical analyses were based on the intention-to-treat principle as far as possible, and acknowledged tests were used for data analysis.
Results A total of 23 studies were identified, 19 of which were included. Diacerein was significantly superior to placebo during the active treatment phase (Glass score, 1.50 [95% confidence interval, 0.80-2.20]). Both diacerein and nonsteroidal anti-inflammatory drugs (NSAIDs) were similarly efficacious during the treatment period; however, diacerein, but not NSAIDs, showed a carryover effect, persisting up to 3 months after treatment, with a significant analgesic-sparing effect during the follow-up period (Glass score, 2.06 [95% confidence interval, 0.66-3.46]). Tolerability assessment revealed no differences between diacerein and NSAIDs, although the latter showed more severe events.
Conclusion This systematic meta-analysis provides evidence for the symptomatic efficacy of diacerein in the treatment of knee and hip osteoarthritis, with reasonable tolerability.
Author Affiliations: Second Department of Medicine, Lower Austrian Centre for Rheumatology, Humanis Klinikum Stockerau, Stockerau, Austria (Drs Rintelen and Leeb); and Executive Information Service Ltd, Vienna, Austria (Mr Neumann).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch et al.
BMJ 2010;341:c3515-c3515.
ABSTRACT
| FULL TEXT
Effects of diacerein at the molecular level in the osteoarthritis disease process
Martel-Pelletier and Pelletier
Therapeutic Advances in Musculoskeletal Diseases 2010;2:95-104.
ABSTRACT
Current evidence for osteoarthritis treatments
Anandacoomarasamy and March
Therapeutic Advances in Musculoskeletal Diseases 2010;2:17-28.
ABSTRACT
The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study
Nuesch et al.
BMJ 2009;339:b3244-b3244.
ABSTRACT
| FULL TEXT
On "Effectiveness of nonpharmacological and nonsurgical interventions..." Moe et al. Phys Ther. 2008;88: 1716-1727.
Leeb and Rintelen
ptjournal 2008;88:407-408.
FULL TEXT
Author Response
Moe et al.
ptjournal 2008;88:408-408.
FULL TEXT
Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review
Olivo et al.
ptjournal 2008;88:156-175.
ABSTRACT
| FULL TEXT
Effectiveness of Nonpharmacological and Nonsurgical Interventions for Hip Osteoarthritis: An Umbrella Review of High-Quality Systematic Reviews
Moe et al.
ptjournal 2007;87:1716-1727.
ABSTRACT
| FULL TEXT
Review: diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis
Hunter and Wise
Evid. Based Med. 2007;12:74-74.
FULL TEXT
|
